Apexigen, Inc.
APGN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Valuation | |||
| PEG Ratio | -0.01 | -0.48 | 0.00 |
| FCF Yield | -227.86% | -7.70% | -6.03% |
| EV / EBITDA | 0.04 | -9.98 | -12.56 |
| Quality | |||
| ROIC | -493.64% | -128.45% | -47.44% |
| Gross Margin | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.96 | 0.83 | 0.83 |
| Growth | |||
| Revenue 3-Year CAGR | – | -100.00% | -100.00% |
| Free Cash Flow Growth | -28.36% | -20.04% | 0.00% |
| Safety | |||
| Net Debt / EBITDA | 0.45 | 0.79 | 0.99 |
| Interest Coverage | 52.98 | 0.00 | 0.00 |
| Efficiency | |||
| Inventory Turnover | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 |